AU2020901573A0 - Compositions for the Treatment of Diseases and Conditions - Google Patents

Compositions for the Treatment of Diseases and Conditions

Info

Publication number
AU2020901573A0
AU2020901573A0 AU2020901573A AU2020901573A AU2020901573A0 AU 2020901573 A0 AU2020901573 A0 AU 2020901573A0 AU 2020901573 A AU2020901573 A AU 2020901573A AU 2020901573 A AU2020901573 A AU 2020901573A AU 2020901573 A0 AU2020901573 A0 AU 2020901573A0
Authority
AU
Australia
Prior art keywords
diseases
compositions
treatment
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020901573A
Inventor
Gerrard Twomey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2020901573A0 publication Critical patent/AU2020901573A0/en
Abandoned legal-status Critical Current

Links

AU2020901573A 2020-05-15 Compositions for the Treatment of Diseases and Conditions Abandoned AU2020901573A0 (en)

Publications (1)

Publication Number Publication Date
AU2020901573A0 true AU2020901573A0 (en) 2020-05-28

Family

ID=

Similar Documents

Publication Publication Date Title
EP3908374A4 (en) Compositions and methods for diagnosis and treatment of neurodegenerative diseases
EP3969597A4 (en) Compositions and methods for the treatment of atpase-mediated diseases
EP3906043A4 (en) Methods and compositions for the treatment of fabry disease
EP3761970A4 (en) Compositions and methods for the treatment of neurological diseases
EP4054713A4 (en) Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
IL272253A (en) Compositions and methods for treatment of inflammatory conditions and diseases of the skin
GB202010464D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP3877383A4 (en) Compounds and compositions for the treatment of respiratory diseases
IL287802A (en) Compositions and methods for treatment of ocular diseases
EP4110369A4 (en) Methods of treatment and related compositions
EP4100406A4 (en) Compositions for treatment of ocular diseases
EP4171606A4 (en) Compositions and methods for the treatment of covid-19
EP3866790A4 (en) Methods and compositions for treatment of glaucoma and related conditions
EP4138852A4 (en) Compositions and methods for the treatment of pain
EP4100029A4 (en) Compositions and methods of use thereof for treatment of mastitis
EP4087847A4 (en) Compositions and methods for the treatment of neurodegenerative diseases
EP4099997A4 (en) Methods and compositions for treatment of diseases
EP3914263A4 (en) Methods and compositions for the treatment and prevention of ocular diseases and conditions
EP4175978A4 (en) Compositions and methods for treating crp-mediated diseases
EP4096653A4 (en) Compositions for the treatment of angiolipoma
EP3917949A4 (en) Compositions and methods for treatment of diseases involving cxcl1 function
AU2021902146A0 (en) Compositions for the Treatment of Diseases and Conditions
AU2020901573A0 (en) Compositions for the Treatment of Diseases and Conditions
EP4106874A4 (en) Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease
EP3987032A4 (en) Methods and compositions for the treatment of cancer